ASTRAZENECA has announced a four-way collaboration which will strengthen the pharmaceutical giant’s link with Cambridge University.
The firm, together with its biologics research and development arm MedImmune, has agreed the new collaboration as it prepares to move its global headquarters to the city. It builds on an existing strategic partnership between the organisations.
{iframe}http://www.cambridge-news.co.uk/AstraZeneca-MedImmune-announce-new-collaboration/story-23202293-detail/story.html{/iframe}